Sympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass

BMC Physiology

Volumn 14, Issue 1, 2014, Pages

  Pliquett, Rainer U ^a,b   Benkhoff, Sebastian ^a   Jung, Oliver ^a   Brandes, Ralf P ^a  

^a GOETHE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Arterial hypertension; Baroreflex; Irbesartan; Sympathetic nervous system

Indexed keywords

ISOQUINOLINE DERIVATIVE; PIPERIDINE DERIVATIVE; RHO KINASE; SAR407889A;

ADRENERGIC SYSTEM; ANIMAL; ARTICLE; BLOOD PRESSURE; C57BL MOUSE; CHOLINERGIC SYSTEM; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; HEART RATE; KIDNEY; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR REFLEX; RENOVASCULAR HYPERTENSION; URINE;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART RATE; HYPERTENSION, RENOVASCULAR; ISOQUINOLINES; KIDNEY; MICE; MICE, INBRED C57BL; PARASYMPATHETIC NERVOUS SYSTEM; PIPERIDINES; RHO-ASSOCIATED KINASES; SYMPATHETIC NERVOUS SYSTEM;

EID: 84902714403     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-14-4     Document Type: Article

References (56)

1. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA: The Journal of the American Medical Association 2007 298 2038 2047 (Pubitemid 350074801)
2. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program: the hypertension detection and follow-up program cooperative group. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA, Hypertension 1989 13 80 I93
3. Stenting and medical therapy for atherosclerotic renal-artery stenosis. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD, CORAL Investigators, N Engl J Med 2013 370 13 22
4. Revascularization versus medical therapy for renal-artery stenosis. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J, ASTRAL Investigators, N Engl J Med 2009 361 1953 1962
5. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group, N Engl J Med 2001 345 851 860
6. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: the collaborative study group. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, N Engl J Med 1993 329 1456 1462 (Pubitemid 23335891)
7. Reduced spontaneous baroreceptor sensitivity in patients with renovascular hypertension. Gao SA, Johansson M, Rundqvist B, Lambert G, Jensen G, Friberg P, J Hypertens 2002 20 111 116 (Pubitemid 34913409)
8. Time course of cardiac sympathetic and vagal tone changes in renovascular hypertensive rats. Cabrai AM, Vasquez EC, Am J Hypertens 1991 4 815 819
9. Changes in hemodynamic and neurohumoral control cause cardiac damage in one-kidney, one-clip hypertensive mice. Borges GR, Salgado HC, Silva CA, Rossi MA, Prado CM, Fazan R, Am J Physiol Regul Integr Comp Physiol 2008 295 1904 R1913
10. Limited effect of systemic + beta-blockade on sympathetic outflow. Tank J, Diedrich A, Schroeder C, Stoffels M, Franke G, Sharma AM, Luft FC, Jordan J, Hypertension 2001 38 1377 1381 (Pubitemid 34033419)
11. Propranolol effects on autonomic function in hypertensive men. O'Connor DT, Preston RA, Clin Cardiol 1982 5 340 346 (Pubitemid 12019502)
12. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T, Hypertension 1997 29 1025 1030 (Pubitemid 27152476)
13. Circulating angiotensin II attenuates the sympathetic baroreflex by reducing the barosensitivity of medullary cardiovascular neurones in the rat. McMullan S, Goodchild AK, Pilowsky PM, J Physiol 2007 582 711 722 (Pubitemid 47040554)
14. Rho kinases in cardiovascular physiology and pathophysiology. Loirand G, Guérin P, Pacaud P, Circ Res 2006 98 322 334
15. Rho-rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Fukata Y, Amano M, Kaibuchi K, Trends Pharmacol Sci 2001 22 32 39 (Pubitemid 32126284)
16. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. van Nieuw Amerongen GP, van DS, Vermeer MA, Collard JG, van HV, Circ Res 2000 87 335 340 (Pubitemid 30655976)
17. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Laufs U, Kilter H, Konkol C, Wassmann S, Bohm M, Nickenig G, Cardiovasc Res 2002 53 911 920 (Pubitemid 34261029)
18. Statin therapy restores sympathovagal balance in experimental heart failure. Pliquett RU, Cornish KG, Zucker IH, J Appl Physiol 2003 95 700 704 (Pubitemid 36944294)
19. Simvastatin normalizes autonomic neural control in experimental heart failure. Pliquett RU, Cornish KG, Peuler JD, Zucker IH, Circulation 2003 107 2493 2498 (Pubitemid 36605234)
20. Central rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure. Haack KKV, Gao L, Schiller AM, Curry PL, Pellegrino PR, Zucker IH, Hypertension 2013 61 723 729
21. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats. Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA, Fundamental & Clinical Pharmacology 2003 17 83 91 (Pubitemid 36241457)
22. Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta. Nap A, Balt JC, Pfaffendorf M, Van Zwieten PA, J Hypertens 2002 20 1821 1828
23. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Ye S, Zhong H, Duong VN, Campese VM, Hypertension 2002 39 1101 1106 (Pubitemid 34620131)
24. AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Zhang J, Leenen FH, Am J Physiol Heart Circ Physiol 2001 280 1318 H1323
25. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP, Circulation 2004 109 1795 1801 (Pubitemid 38500684)
26. Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice. Baudrie V, Laude D, Elghozi JL, Am J Physiol Regul Integr Comp Physiol 2007 292 904 R912
27. Power spectral analysis in mice: what are the appropriate frequency bands? Stauss HM, Am J Physiol Regul Integr Comp Physiol 2007 292 902 R903
28. Effect of baroreceptor denervation on the autonomic control of arterial pressure in conscious mice. Rodrigues FL, de OM, Salgado HC, Fazan R Jr, Exp Physiol 2011 96 853 862
29. Acute and chronic stress influence blood pressure variability in mice. Farah VM, Joaquim LF, Bernatova I, Morris M, Physiol Behav 2004 83 135 142 (Pubitemid 39387702)
30. Alpha-2 adrenergic transmission and human baroreflex regulation. Tank J, Diedrich A, Szczech E, Luft FC, Jordan J, Hypertension 2004 43 1035 1041 (Pubitemid 38579910)
31. A new approach to analysis of the arterial baroreflex. Bertinieri G, Di RM, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G, J Hypertens Suppl 1985 3 79 S81
32. Applicability of recent methods used to estimate spontaneous baroreflex sensitivity to resting mice. Laude D, Baudrie V, Elghozi JL, Am J Physiol Regul Integr Comp Physiol 2008 294 142 R150
33. Excretion and metabolism of catecholamines by the isolated perfused rat kidney. Silva P, Landsberg L, Besarab A, J Clin Invest 1979 64 850 857 (Pubitemid 10223766)
34. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Bailey SR, Eid AH, Mitra S, Flavahan S, Flavahan NA, Circ Res 2004 94 1367 1374 (Pubitemid 38724483)
35. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Jin L, Ying Z, Webb RC, Am J Physiol Heart Circ Physiol 2004 287 1495 H1500
36. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Dobrian AD, Schriver SD, Prewitt RL, Hypertension 2001 38 361 366 (Pubitemid 34225666)
37. Hypertension is critically dependent on the carotid body input in the spontaneously hypertensive rat. Abdala AP, McBryde FD, Marina N, Hendy EB, Engelman ZJ, Fudim M, Desir GV, et al. J Physiol 2012 590 4269 4277
38. Relation between baroreflex sensitivity and cardiac vagal tone in humans. Kollai M, Jokkel G, Bonyhay I, Tomcsanyi J, Naszlady A, Am J Physiol Heart Circ Physiol 1994 266 21 H27
39. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. Chern CM, Hsu HY, Hu HH, Chen YY, Hsu LC, Chao AC, J Cardiovasc Pharmacol 2006 47 169 174
40. Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure. Ramchandra R, Watson AMD, Hood SG, May CN, Am J Physiol Regul Integr Comp Physiol 2010 298 1056 R1060
41. Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats. Shang W, Han P, Yang C, Gu XW, Zhang W, Xu LP, Fu ST, Su DF, Xie HH, Acta Pharmacol Sin 2011 32 1109 1115
42. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension. Alnima T, de Leeuw PW, Tan FES, Kroon AA, Hypertension 2013 61 1334 1339
43. Acute AT1 receptor blockade does not improve the depressed baroreflex in rats with chronic renal hypertension. Farah VM, Moreira ED, Ushizima M, Cestari IA, Irigoyen MC, Krieger EM, Braz J Med Biol Res 2000 33 1491 1496 (Pubitemid 32094871)
44. Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. Oliveira-Sales EB, Toward MA, Campos RR, Paton JF, Auton Neurosci 2014 183 23 29
45. Changes in the central ANF-system of renovascular hypertensive rats. Bahner U, Geiger H, Palkovits M, Ganten D, Klotz B, Heidland A, Kidney Int 1991 39 33 38
46. Noradrenaline release and the pathophysiology of primary human hypertension. Esler M, Jennings G, Lambert G, Am J Hypertens 1989 2 140S 146S (Pubitemid 19082354)
47. Plasma catecholamines and essential hypertension: an analytical review. Goldstein DS, Hypertension 1983 5 86 99 (Pubitemid 13179794)
48. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M, Hypertension 1989 13 870 877 (Pubitemid 19157983)
49. Single-unit sympathetic discharge: quantitative assessment in human hypertensive disease. Greenwood JP, Stoker JB, Mary DASG, Circulation 1999 100 1305 1310 (Pubitemid 29440123)
50. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Zucker IH, Schultz HD, Patel KP, Wang W, Gao L, Am J Physiol Heart Circ Physiol 2009 297 1557 H1566
51. Superoxide mediates the actions of angiotensin II in the central nervous system. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL, Circ Res 2002 91 1038 1045 (Pubitemid 35416641)
52. Brain amiloride-sensitive Phe-Met-Arg-Phe-NH2-gated Na + channels and Na + -induced sympathoexcitation and hypertension. Huang BS, Leenen FHH, Hypertension 2002 39 557 561 (Pubitemid 34165182)
53. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV, J Clin Invest 2005 115 1275 1280 (Pubitemid 40629046)
54. Catecholamines regulate the activity, secretion, and synthesis of renalase. Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, Desir GV, Circulation 2008 117 1277 1282 (Pubitemid 351365660)
55. Renalase deficiency in heart failure model of rats-a potential mechanism underlying circulating norepinephrine accumulation. Gu R, Lu W, Xie J, Bai J, Xu B, PLoS ONE 2011 6 14633
56. Nitric oxide synthesis inhibition retards surgical reversal of one-kidney goldblatt hypertension in rats. Huang WC, Tsai RY, Hypertension 1998 32 534 540